Børsen
On Monday, Novo Nordisk purchased three key filling factories for 11 billion dollars – 76 billion kroner – to help the company meet the demand for GLP-1 drugs, according to a stock exchange announcement.
On Monday, Novo Nordisk purchased three key filling factories for 11 billion dollars – 76 billion kroner – to help the company meet the demand for GLP-1 drugs, according to a stock exchange announcement.